FDA: Merck allergy drug may have suicide link

Tools

FDA logo

By Associated Press

Story Published: Mar 27, 2008 at 10:21 AM PST

WASHINGTON (AP) - The Food and Drug Administration said Thursday it is investigating a possible link between Merck's allergy drug Singulair and suicide.

FDA said it is reviewing reports of mood changes, suicidal behavior and suicide in patients who have taken the drug, which was Merck's best-selling product last year.

In the past year Merck has updated the drug's labeling four times to include information on tremors, anxiousness, depression and suicidal behavior reported in some patients.

Singulair had sales of $4.3 billion last year.

Shares of Merck & Co. Inc. fell 10 cents to $44.60 in late morning trading.

Current Weather

Icon
Current Temp 53.0 °F
Overcast
Video
More Weather

Upload directly from your mobile device.

Learn how

YouNews

This content requires the latest Adobe Flash Player and a browser with JavaScript enabled. Click here for a free download of the latest Adobe Flash Player.

On Demand

Resources and info you need to prepare for the switch to DTV.

Stay Connected

POLL: Winter weather

Has the weather disrupted your work, school or play?

  • Yes
  • No
  • I wish!